Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Kibow Biotech has reported that it has been granted an international patent cooperation treaty patent from Australia, China and India.
Subscribe to our email newsletter
The approved patent protects the composition and method behind the company’s oral probiotic product formulation Kibow Biotics, which may significantly reduce concentrations of several nitrogenous waste metabolites that accumulate in renal deficiency.
Natarajan Ranganathan, vice president of R&D and interim CEO, Kibow, said: “The rapidly expanding intellectual property portfolio for our unique ‘enteric dialysis’ platform technology has added immense potential to our company products for kidney failure applications worldwide.”